Milestone Pharmaceuticals’ (MIST) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Free Report) in a research note released on Thursday, Benzinga reports. HC Wainwright currently has a $25.00 price target on the stock. Separately, Piper Sandler lowered their price target on Milestone Pharmaceuticals from $6.00 to $5.00 and set an overweight rating for […]
More Stories
Netflix’s Upcoming Documentary: A Child of My Own Release Date and More
Are you also interested in watching the real-life documentary? If yes, then this blog is for you. One of the...
Announcement! 1670 Season 4 is Releasing Soon! Release Date, Trailer Updates, and More
Hello! Polish TV series and movie fans. 1670 is going to end soon. With great reviews and huge viewership, the...
Semrush vs Serpstat vs Ahrefs: Which Is Better?
No business today can skip search engine optimization if they want to lead in the online marketplace. From keyword research...
Murder in a Small Town Season 3 Is Releasing Soon on Netflix
Murder in a Small Town Season 3 is coming back with an-all-new drama and suspenseful storyline for its viewers. The...
Netflix’s Fauda Season 5: Release Date, Cast Members, Plot, and Episodes
Fauda season 5 is coming to Netflix soon! Your years of waiting are finally over. Are you also one of...
How to Cancel Hulu Subscriptions? A Complete Guide For Beginners
Worried about your money being deducted? Do you also have a subscription and now don’t know how to cancel your...